Literature DB >> 8524320

Activation of transcription by PU.1 requires both acidic and glutamine domains.

M J Klemsz1, R A Maki.   

Abstract

The B-lymphocyte- and macrophage-specific transcription factor PU.1 is a member of the ets family of proteins. To understand how PU.1 functions as a transcription factor, we initiated a series of experiments to define its activation domain. Using deletion analysis, we showed that the activation domain of PU.1 is located in the amino-terminal half of the protein. Within this region, we identified three acidic subdomains and one glutamine-rich subdomain. The deletion of any of these subdomains resulted in a significant loss in the ability of PU.1 to transactivate in cotransfection studies. Amino acid substitution analysis showed that the activation of transcription by PU.1 requires acidic residues between amino acids 7 and 74 and a group of glutamine residues between amino acids 75 and 84. These data show that PU.1 contains two types of known activation domains and that both are required for maximal transactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8524320      PMCID: PMC231014          DOI: 10.1128/MCB.16.1.390

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.

Authors:  J M Hardwick; L Tse; N Applegren; J Nicholas; M A Veliuona
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.

Authors:  F D Karim; L D Urness; C S Thummel; M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki; C V Gunther; J A Nye
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

3.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Critical structural elements of the VP16 transcriptional activation domain.

Authors:  W D Cress; S J Triezenberg
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

5.  PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.

Authors:  C F Eisenbeis; H Singh; U Storb
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

6.  Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element.

Authors:  M K Shin; M E Koshland
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

7.  Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.

Authors:  D L Galson; J O Hensold; T R Bishop; M Schalling; A D D'Andrea; C Jones; P E Auron; D E Housman
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.

Authors:  B Nelsen; G Tian; B Erman; J Gregoire; R Maki; B Graves; R Sen
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

9.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

10.  Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions.

Authors:  K Seipel; O Georgiev; W Schaffner
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  28 in total

1.  Do lampreys have lymphocytes? The Spi evidence.

Authors:  S Shintani; J Terzic; A Sato; M Saraga-Babic; C O'hUigin; H Tichy; J Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Mi2beta shows chromatin enzyme specificity by erasing a DNase I-hypersensitive site established by ACF.

Authors:  Haruhiko Ishii; Hansen Du; Zhaoqing Zhang; Angus Henderson; Ranjan Sen; Michael J Pazin
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

5.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

6.  Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.

Authors:  M S Petrovick; S W Hiebert; A D Friedman; C J Hetherington; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60.

Authors:  P A Defossez; J L Baert; M Monnot; Y de Launoit
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

8.  PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

Authors:  J M Pongubala; M L Atchison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

9.  PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.

Authors:  Natasha Rekhtman; Kevin S Choe; Igor Matushansky; Stuart Murray; Tomas Stopka; Arthur I Skoultchi
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.